Eli Lilly, facing a lawsuit by Sanofi SA, said it doesn't believe one of its proposed new insulin products infringes upon patents covering Sanofi's Lantus insulin.
from WSJ.com: US Business http://ift.tt/1klzaM1
via IFTTT
from WSJ.com: US Business http://ift.tt/1klzaM1
via IFTTT
No comments:
Post a Comment